Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Reem Abou Assi"'
Autor:
Siok Sin Chan, Theam Foo Ng, Mohd Sayuti Hassan, Chee Keat Ying, Mei Lan Tan, Siti Fairuz Mohd Radzi, Reem Abou Assi, Siok-Yee Chan
Publikováno v:
Frontiers in Environmental Science, Vol 10 (2022)
This work is reporting the advocation of a public Malaysia University for the environmental protection through sustainable waste practices ever since its ban on the use of the “White Coffin” initiative in circa 2008, a flagship for environmental
Externí odkaz:
https://doaj.org/article/41bf58fc0a1d43e6b7e3561db0b8b9ff
Autor:
Arshad Ali Khan, Ibrahim M. Abdulbaqi, Reem Abou Assi, Vikneswaran Murugaiyah, Yusrida Darwis
Publikováno v:
Nanoscale Research Letters, Vol 13, Iss 1, Pp 1-16 (2018)
Abstract Verapamil is a calcium channel blocker and highly effective in the treatment of hypertension, angina pectoris, and other diseases. However, the drug has a low bioavailability of 20 to 35% due to the first pass effect. The main objective of t
Externí odkaz:
https://doaj.org/article/77f17de4871f4bc3bdd81b945be9c5aa
Publikováno v:
Water, Vol 13, Iss 15, p 2018 (2021)
The water crisis is identified as the most serious global risk for the coming decade. Distilled water is one of the on-demand elements in academic laboratories; however, water scarcity may eventually affect the education sector, necessitating the imp
Externí odkaz:
https://doaj.org/article/ad1642be99184f7b86d1de34822f2d98
Autor:
Ibrahim M. Abdulbaqi, Reem Abou Assi, Anan Yaghmur, Yusrida Darwis, Noratiqah Mohtar, Thaigarajan Parumasivam, Fadi G. Saqallah, Habibah A. Wahab
Publikováno v:
Pharmaceuticals, Vol 14, Iss 8, p 725 (2021)
Lung cancer (LC) is the leading cause of cancer-related deaths, responsible for approximately 18.4% of all cancer mortalities in both sexes combined. The use of systemic therapeutics remains one of the primary treatments for LC. However, the therapeu
Externí odkaz:
https://doaj.org/article/aaba251449bc4f569ff2718d7a285f46
Autor:
Reem Abou Assi, Yusrida Darwis, Ibrahim M. Abdulbaqi, Arshad A. khan, Lim Vuanghao, M.H. Laghari
Publikováno v:
Arabian Journal of Chemistry, Vol 10, Iss 5, Pp 691-707 (2017)
Traditional medical practitioners in Hawaii and Polynesia have used Morinda citrifolia L. (Noni) for centuries to cure or prevent varieties of illnesses. The popularity of M. citrifolia as a dietary supplement, a food functional ingredient, or as a n
Externí odkaz:
https://doaj.org/article/7b54ff889b154a398684f1abb74eaaef
Publikováno v:
Pharmaceuticals, Vol 14, Iss 3, p 215 (2021)
Current research indicates that the next silent epidemic will be linked to chronic liver diseases, specifically non-alcoholic fatty liver disease (NAFLD), which was renamed as metabolic-associated fatty liver disease (MAFLD) in 2020. Globally, MAFLD
Externí odkaz:
https://doaj.org/article/9e5523882abd4130b019040f6907cf2d
Autor:
Reem Abou Assi, Ibrahim M. Abdulbaqi, Toh Seok Ming, Chan Siok Yee, Habibah A. Wahab, Shaik Mohammed Asif, Yusrida Darwis
Publikováno v:
Pharmaceutics, Vol 12, Iss 11, p 1052 (2020)
Azithromycin (AZM) is a macrolide antibiotic used for the treatment of various bacterial infections. The drug is known to have low oral bioavailability (37%) which may be attributed to its relatively high molecular weight, low solubility, dissolution
Externí odkaz:
https://doaj.org/article/c2ab8bdba0ad49569429a37752c9aa68
Autor:
Siew Mei Tan, Xin Yi Teoh, Jia Le Hwang, Zhao Peng Khong, Rana Sejare, Abdulsalam Q. Almashhadani, Reem Abou Assi, Siok Yee Chan
Publikováno v:
Journal of Drug Delivery Science and Technology. 76:103761
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::646c93e4fd41384aa4177a9f7ed62d07
https://doi.org/10.1016/j.jddst.2022.103761
https://doi.org/10.1016/j.jddst.2022.103761
Publikováno v:
Drug Design, Development and Therapy
Ibrahim M Abdulbaqi, Yusrida Darwis, Reem Abou Assi, Nurzalina Abdul Karim Khan School of Pharmaceutical Sciences, Universiti Sains Malaysia, Minden, Penang, Malaysia Introduction: Colchicine is used for the treatment of gout, pseudo-gout, familial M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1ec8f252a7ae3cda793236d7cef529c
https://doi.org/10.2147/dddt.s158018
https://doi.org/10.2147/dddt.s158018
Autor:
Yusrida Darwis, Noratiqah Mohtar, Anan Yaghmur, Ibrahim M. Abdulbaqi, Habibah A. Wahab, Thaigarajan Parumasivam, Reem Abou Assi, Fadi G Saqallah
Publikováno v:
Pharmaceuticals
Pharmaceuticals, Vol 14, Iss 725, p 725 (2021)
Abdulbaqi, I M, Assi, R A, Yaghmur, A, Darwis, Y, Mohtar, N, Parumasivam, T, Saqallah, F G & Wahab, H A 2021, ' Pulmonary Delivery of Anticancer Drugs via Lipid-Based Nanocarriers for the Treatment of Lung Cancer : An Update ', Pharmaceuticals, vol. 14, no. 8, 725 . https://doi.org/10.3390/ph14080725
Pharmaceuticals, Vol 14, Iss 725, p 725 (2021)
Abdulbaqi, I M, Assi, R A, Yaghmur, A, Darwis, Y, Mohtar, N, Parumasivam, T, Saqallah, F G & Wahab, H A 2021, ' Pulmonary Delivery of Anticancer Drugs via Lipid-Based Nanocarriers for the Treatment of Lung Cancer : An Update ', Pharmaceuticals, vol. 14, no. 8, 725 . https://doi.org/10.3390/ph14080725
Lung cancer (LC) is the leading cause of cancer-related deaths, responsible for approximately 18.4% of all cancer mortalities in both sexes combined. The use of systemic therapeutics remains one of the primary treatments for LC. However, the therapeu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3523d747e2dbd55cbf2866e995ff0a1c
https://doi.org/10.3390/ph14080725
https://doi.org/10.3390/ph14080725